These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 33982338)
1. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function. Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338 [TBL] [Abstract][Full Text] [Related]
2. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067 [TBL] [Abstract][Full Text] [Related]
3. [Gene therapy for muscular dystrophy]. Takeda S No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985 [TBL] [Abstract][Full Text] [Related]
4. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755 [TBL] [Abstract][Full Text] [Related]
5. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice. Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083 [TBL] [Abstract][Full Text] [Related]
7. Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype. Wasala NB; Lai Y; Shin JH; Zhao J; Yue Y; Duan D Hum Mol Genet; 2016 Jul; 25(13):2633-2644. PubMed ID: 27106099 [TBL] [Abstract][Full Text] [Related]
8. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914 [TBL] [Abstract][Full Text] [Related]
14. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Watchko J; O'Day T; Wang B; Zhou L; Tang Y; Li J; Xiao X Hum Gene Ther; 2002 Aug; 13(12):1451-60. PubMed ID: 12215266 [TBL] [Abstract][Full Text] [Related]
18. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500 [TBL] [Abstract][Full Text] [Related]
19. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy. Guo Y; Petrof BJ; Hussain SN Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948 [TBL] [Abstract][Full Text] [Related]
20. AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice. Heller KN; Montgomery CL; Janssen PM; Clark KR; Mendell JR; Rodino-Klapac LR Mol Ther; 2013 Mar; 21(3):520-5. PubMed ID: 23319059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]